Andrew A. Smith - 30 Jun 2025 Form 3/A - Amendment Insider Report for Medicus Pharma Ltd. (MDCX)

Role: Chief Operating Officer
Signature: /s/ Andrew A. Smith
Issuer symbol: MDCX
Transactions as of: 30 Jun 2025
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 06 Aug 2025, 16:36:34 UTC
Date Of Original Report: 03 Jul 2025
Next filing: 18 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Smith Andrew Alasdair	Chief Operating Officer	300 CONSHOHOCKEN STATE ROAD, SUITE 200, W. CONSHOHOCKEN	/s/ Andrew A. Smith	06 Aug 2025	0001309614

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MDCX	Common Shares, no par value ("Common Shares")						164	30 Jun 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MDCX	Stock Option (right to buy)							30 Jun 2025	Common Shares	100,000	$2.60	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment is being filed to include Common Shares that were inadvertently omitted from the Form 3 filed by the Reporting Person on July 3, 2025.
F2	The board of directors of Medicus Pharma Ltd. (the "Board") approved, during a Board meeting held on July 22, 2025, accelerated vesting of the Reporting Person's options that were otherwise unvested and scheduled to vest annually in five equal installments beginning on June 30, 2026. All these options are now vested.